leflunomide has been researched along with Atrophy in 1 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Primary IgA nephropathy (IgAN) and HSPN share common features; thus, the Oxford classification of IgAN might be useful in predicting the long-term outcomes of HSPN." | 1.48 | Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis. ( Ding, J; Li, Y; Su, B; Wang, F; Wang, S; Xiao, H; Xu, K; Zhang, L; Zhong, X, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, K | 1 |
| Zhang, L | 1 |
| Ding, J | 1 |
| Wang, S | 1 |
| Su, B | 1 |
| Xiao, H | 1 |
| Wang, F | 1 |
| Zhong, X | 1 |
| Li, Y | 1 |
1 other study available for leflunomide and Atrophy
| Article | Year |
|---|---|
Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
Topics: Adolescent; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Atrophy; Biopsy; Child; Child, Pr | 2018 |